GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

The weight of being a Hollywood star can take a toll on a person’s weight.In an industry obsessed with physical appearance, a ...

In the glittering world of celebrity-endorsed weight loss transformations and viral before-and-after photos, a darker narrative is emerging from the shadows ...

Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...

Administered as a once-weekly subcutaneous injection, Ozempic not only helps control blood glucose levels but also reduces ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye conditions.

It is present in low-calorie food and drinks and some medications ... concluding that aspartame may have adverse effects on metabolism. Ultimately, more research in humans is necessary for ...

In some cases, they may be able to treat your eye side effects. In other, more serious cases, they may have you stop taking Velcade and switch to a different medication to treat your cancer.

Benzalkonium chloride is the most common preservative in antiglaucoma preparations and its toxic effects depend ... Chronic use of glaucoma drugs may lead to ocular surface changes, causing ...

The average vision gains from baseline were comparable between the two treatments in both studies, according to Roche, equivalent to around 17 letters on a standard eye chart. Roche's drug was ...